Pet Care Stocks & Investments (List) (pet products, services, etc.)

Pet Care Stocks & Investments (List)

Are you looking to invest in the thriving pet care industry? With the increasing demand for pet products and services, the pet care sector presents exciting investment opportunities. From pet food and healthcare to grooming and accessories, there are numerous areas within the pet industry to explore.

The U.S. pet industry is experiencing impressive growth, with sales of pet-related products reaching a staggering $69.51 billion in 2017. Veterinary services and the pet food market have contributed significantly to this upward trend. In fact, industry experts estimate that the pet care market will surpass $86 billion by the end of this year.

If you’re considering investing in pet products or services, it’s essential to be aware of the key players in the market. Here are some notable stocks in the pet care industry:

Zoetis (ZTS) – As the leading animal health company, Zoetis produces a wide range of pharmaceuticals, vaccines, and medicated food additives. With its focus on improving the health of both livestock and pets, Zoetis is considered a safe bet in the animal-related stock market.

Central Garden & Pet Company (CENT) – Known for manufacturing products for the lawn and garden market, Central Garden & Pet Company also has a profitable pet segment that accounts for over 60% of its revenue. From edible bones and treats to toys and grooming supplies, the company offers a diverse range of pet supplies.

Freshpet (FRPT) – If you’re interested in natural pet foods, Freshpet is a major player in the market. The company specializes in refrigerated meals for dogs and cats and distributes its products through various retail channels, including mass, grocery, pet specialty, and online.

Trupanion (TRUP) – Considered a leading provider of pet insurance, Trupanion offers coverage for dogs and cats in the U.S., Canada, and Puerto Rico. With the pet insurance industry booming, investing in Trupanion stock could be a smart move for those looking to capitalize on this growing trend.

Merck & Co. (MRK) – A global healthcare solutions company, Merck & Co. also has an animal health segment that produces ointments, medicine, and feed additives for dogs and cats. Although animal health products account for a smaller portion of their sales, Merck & Co. is one of the largest animal health conglomerates in the world.

Aratana Therapeutics (PETX) – Specializing in pharmaceuticals for cats and dogs, Aratana Therapeutics focuses on licensing, developing, and distributing drugs for various pet health conditions, including cancer treatment and viral diseases. Market analysts consider now a good time to consider investing in their stock.

Investing in pet care stocks can be a lucrative venture. However, it’s important to conduct thorough research and analysis before making any investment decisions. Factors such as competition, financials, brand value, market share, innovation, and supply chain should all be considered.

As the pet care industry continues to grow, there are ample investment opportunities for those interested in this sector. Just remember to approach investments with due diligence and a long-term mindset.

Key Takeaways:

  • Investing in the pet care industry offers exciting opportunities due to its steady growth.
  • Notable pet care stocks include Zoetis, Central Garden & Pet Company, Freshpet, Trupanion, Merck & Co., and Aratana Therapeutics.
  • Market analysis and evaluation are crucial before investing in pet care stocks.
  • Factors to consider include competition, financials, brand value, market share, innovation, and supply chain.
  • The pet care industry is expected to continue growing, making it an appealing investment prospect.

Zoetis (ZTS)

Zoetis is the leading animal health company specializing in pet healthcare products, pharmaceuticals, and veterinary services. With a strong focus on improving the health and well-being of both livestock and pets, Zoetis has established itself as a trusted name in the industry.

As an animal health company, Zoetis produces a wide range of products including parasiticides, vaccines, and medicated food additives. These products play a crucial role in preventing and treating various health conditions in animals, ensuring their overall health and longevity.

Since its spin-off from Pfizer in 2013, Zoetis stock has experienced impressive growth, nearly doubling in value. This makes Zoetis one of the safest bets in the animal-related stock market, attracting the attention of investors looking for stable returns in the pet industry.

By continuously investing in research and development, Zoetis remains at the forefront of innovation in the animal health sector. The company’s commitment to advancing veterinary medicine and providing effective solutions has solidified its position as an industry leader.

With a global presence and a strong distribution network, Zoetis reaches veterinarians, pet owners, and livestock producers worldwide. This allows them to deliver their high-quality products and services to a diverse range of customers, ensuring animals everywhere receive the best possible care.

Overall, Zoetis’s strong market position, commitment to innovation, and dedication to animal health make it a top choice for investors seeking opportunities in the pet healthcare industry.

Key Products and Services

Product/Service Description
Parasiticides Medications used to treat and prevent parasitic infections in animals, including fleas, ticks, and worms.
Vaccines Immunizations that protect animals against various diseases, helping to prevent outbreaks and maintain overall health.
Medicated Food Additives Supplements added to animal feed to promote health and prevent common nutritional deficiencies.
Veterinary Services Comprehensive healthcare services provided by veterinarians, including consultations, surgeries, and diagnostic tests.

Central Garden & Pet Company (CENT)

Central Garden & Pet Company is a prominent manufacturer of products for the lawn and garden market, as well as the pet segment.

With a vast range of pet supplies, Central Garden & Pet Company caters to the needs of pet owners across the country. Their products include edible bones, dog and cat treats, food, toys, grooming supplies, and much more.

The pet segment of Central Garden & Pet Company contributes significantly to its revenue, accounting for over 60% of its total sales. This highlights the company’s strong foothold in the pet industry.

Central Garden & Pet Company strategically sells its products through various channels, including independent pet distributors, retail chains, and online suppliers. Notable online suppliers include e-commerce giants like Amazon and Chewy, providing pet owners with convenient access to their wide range of pet supplies.

By collaborating with retail chains and online suppliers, Central Garden & Pet Company ensures that their high-quality pet products reach a broader customer base, both in physical stores and online platforms.

Central Garden & Pet Company Revenue Breakdown by Segment

Pet Segment Lawn and Garden Segment
Over 60% Less than 40%

Freshpet (FRPT)

Freshpet is a leading manufacturer and distributor of natural foods and treats for dogs and cats. With a commitment to delivering high-quality, nutritious meals, Freshpet ensures that your furry friends receive the best ingredients for optimal health and wellbeing.

Innovative Refrigerated Meals

What sets Freshpet apart from other pet food brands is their dedication to freshness. Freshpet offers a range of refrigerated meals that provide pets with real, whole ingredients. Their recipes are carefully crafted to meet the nutritional needs of pets, offering a balanced diet without any artificial preservatives, fillers, or by-products.

Distributed Through Retail Classes

Freshpet understands the importance of accessibility for pet owners. That’s why their products are available through various retail channels, including mass retailers, grocery stores, pet specialty shops, and online platforms. This ensures that pet owners can easily find and purchase Freshpet products to provide their pets with wholesome meals.

Meeting Pet Specialty Needs

Freshpet recognizes that pets with specific dietary requirements have unique needs. That’s why they offer specialized formulas for pets with sensitivities or allergies. These pet specialty products are meticulously crafted to address specific concerns while still providing a delicious and nutritious meal.

A Growing Stock with Potential

Though Freshpet stock experienced a decline in 2015, the company has since made a remarkable recovery and is thriving in the pet care market. With the increasing demand for natural pet food options, Freshpet is well-positioned to continue its growth trajectory in the coming years.

Retail and Online Availability

Whether you prefer to shop in-store or online, Freshpet makes it convenient for pet owners to access their products. You can find Freshpet items in traditional retail locations or conveniently order online and have them delivered right to your doorstep.

Retail Channels Availability
Mass retailers
Grocery stores
Pet specialty shops
Online platforms

Trupanion (TRUP)

Trupanion is a leading provider of pet insurance for dogs and cats. The company caters to veterinarians and pet owners in the U.S., Canada, and Puerto Rico. With a focus on providing comprehensive coverage and excellent customer service, Trupanion has become a trusted name in the pet insurance industry.

Trupanion stock has demonstrated consistent growth in recent years, reflecting the increasing demand for pet insurance. As more pet owners recognize the importance of having financial protection for their furry companions, the pet insurance industry is experiencing a significant boom. Trupanion’s commitment to enhancing the lives of pets and their owners has positioned the company for continued success in the future.

Benefits of Trupanion Pet Insurance

Key Benefits Details
Comprehensive Coverage Trupanion offers coverage for a wide range of illnesses, injuries, and treatments, ensuring that pets receive the care they need without financial constraints.
Direct Payment to Veterinarians Trupanion pays veterinarians directly, eliminating the need for upfront payment and reimbursement processes, allowing pet owners to focus on their pet’s well-being.
No Payout Limits Trupanion does not impose annual or lifetime payout limits, ensuring that pets can receive ongoing care throughout their lives.
Flexibility and Customization Trupanion offers different deductible and reimbursement options, allowing pet owners to tailor their policies to their specific needs and budget.

By choosing Trupanion pet insurance, pet owners can have peace of mind knowing that their beloved companions are protected in case of unexpected accidents, illnesses, or injuries. With Trupanion’s commitment to providing high-quality coverage and exceptional service, pet owners can focus on what matters most – the health and happiness of their furry family members.

Merck & Co. (MRK)

Merck & Co. is a global healthcare company that offers a wide range of solutions, including animal health products. With a commitment to improving the health and well-being of animals, Merck & Co.’s Animal Health segment is dedicated to providing high-quality healthcare products for dogs and cats.

The animal health products produced by Merck & Co. include ointments, medicines, and other treatments that cater to the various needs of pets. These products are designed to address common issues such as fleas and ticks, ensuring that pets remain healthy and happy. Additionally, Merck & Co. offers feed additives that help enhance the overall nutrition of animals, promoting their overall well-being.

While animal health products currently account for only around 10% of Merck & Co.’s total sales, the company’s dedication to animal health makes them one of the largest animal health conglomerates in the world. Their commitment to research, development, and innovation ensures that they continue to provide effective solutions for pet owners, veterinarians, and the animal healthcare industry as a whole.

Merck & Co.’s Animal Health Segment

Merck & Co.’s Animal Health segment offers a wide variety of products that cater to the unique needs of pets. From ointments and medicines to feed additives, their range of healthcare solutions ensures that pets receive the care they need to thrive.

Product Function
Ointments Treat various skin conditions, including rashes and irritations
Medicines Address common health issues, such as infections and allergies
Feed Additives Enhance the overall nutrition and well-being of animals

By prioritizing animal health, Merck & Co. contributes to the overall well-being of pets and strengthens the bond between pets and their owners. With their commitment to innovation and excellence, they continue to be a trusted provider of healthcare solutions for the animal health industry.

Aratana Therapeutics (PETX)

Aratana Therapeutics is a leading pharmaceuticals company specializing in the licensing, development, and distribution of innovative drugs and pharmaceutical products for cats and dogs. With a focus on improving the lives of our furry companions, Aratana Therapeutics is at the forefront of creating effective treatments for various conditions in pets.

Our product portfolio includes a range of treatments for cancer, viral diseases, pain management, allergies, and more. We are committed to developing safe and effective therapies that enhance the well-being of pets and provide peace of mind for their owners.

While Aratana Therapeutics has faced challenges in the past, our relentless dedication to research and development has paved the way for remarkable breakthroughs in pet healthcare. We collaborate with renowned veterinarians and experts to ensure the highest standard of quality and efficacy in our products.

Market analysts recognize the immense potential in the pet healthcare industry, and Aratana Therapeutics is well-positioned to capitalize on this growth. Investing in Aratana Therapeutics stock opens up an opportunity to be part of a company that is making a significant impact on the lives of pets and their owners.

Advancing Cancer Treatment for Pets

Cancer is a devastating disease that affects our beloved pets. Aratana Therapeutics is dedicated to advancing the field of cancer treatment for pets, developing therapies that target specific cancer cells while minimizing the side effects.

Our breakthrough therapies are designed to improve survival rates, enhance quality of life, and provide hope for pet owners facing this difficult diagnosis. With ongoing research and development, Aratana Therapeutics is making significant strides in the fight against cancer in pets.

Innovative Solutions for Viral Diseases

Viral diseases can pose significant health risks to pets, impacting their immune system and overall well-being. Aratana Therapeutics is actively developing innovative solutions to combat viral diseases in cats and dogs.

Through cutting-edge research and collaboration with leading experts in virology, we are creating breakthrough therapies that target and neutralize viral pathogens, improving the prognosis and quality of life for pets affected by these diseases.

Investing in Aratana Therapeutics stock not only allows you to be part of this innovative journey but also supports the development of groundbreaking treatments for pets suffering from viral diseases.

Leaders in Licensing and Distribution

Aratana Therapeutics has established itself as a leader in the licensing and distribution of pharmaceutical products for pets. Our strategic partnerships with veterinarians, clinics, and pet suppliers ensure widespread availability of our life-changing therapies.

By leveraging our strong distribution network, we are able to reach pet owners and veterinary professionals across the country, ensuring that our products are readily accessible to those who need them most. This expansive reach further solidifies Aratana Therapeutics’ position as a key player in the pet pharmaceutical industry.

Investing in Aratana Therapeutics stock allows you to support an organization that is actively driving the growth and accessibility of cutting-edge pet pharmaceuticals.

Aratana Therapeutics is dedicated to improving the lives of pets through innovative pharmaceutical solutions. With a robust pipeline of products and a commitment to excellence, we are poised for continued success in the ever-growing pet healthcare industry. Consider investing in Aratana Therapeutics stock and join us in shaping the future of pet healthcare.


The pet care industry is a rapidly growing sector with numerous investment opportunities. As pet ownership and spending on pet-related products continue to rise, investing in pet care stocks can be a lucrative choice. However, before diving into the market, careful analysis and evaluation of various factors are crucial for making informed investment decisions.

When considering pet care stocks, it is important to assess the competitive landscape of the industry. Identifying key players, their market share, and their strategies can give investors valuable insights into the potential growth opportunities and risks associated with specific companies.

Financials and brand value are also crucial factors to consider. Understanding a company’s financial health, profitability, and growth potential is essential to determine its long-term prospects. Additionally, strong brand value and customer loyalty can be indicators of future success in the industry.

Furthermore, an evaluation of innovation and the company’s ability to adapt to changing market trends is vital. The pet care industry is constantly evolving, driven by new product offerings and technological advancements. Investing in companies that prioritize innovation can provide investors with a competitive edge in the market.

Lastly, it is essential to consider the industry’s growth rate and overall economic conditions. Analyzing industry trends, market demand, and macroeconomic factors can help investors gauge the future growth potential of the pet care industry and make well-informed investment decisions.


What are some investment opportunities in the pet care industry?

Some investment opportunities in the pet care industry include stocks in companies involved in pet products, services, veterinary services, pet healthcare, and animal health products.

Which company is considered a safe bet in the animal-related stock market?

Zoetis, the leading animal health company, is considered a safe bet in the animal-related stock market, as it has almost doubled in value since spinning off from its parent company, Pfizer.

What products does Central Garden & Pet Company manufacture?

Central Garden & Pet Company manufactures a wide range of pet supplies, including edible bones, dog and cat treats, food, toys, grooming supplies, and more.

Where does Freshpet sell its pet supplies?

Freshpet sells its natural pet foods and treats through various retail channels, including mass, grocery, club, pet specialty, and online.

What does Trupanion specialize in?

Trupanion specializes in providing pet insurance for dogs and cats in the United States, Canada, and Puerto Rico, serving veterinarians and pet owners.

What types of healthcare solutions does Merck & Co. offer?

Merck & Co. offers various healthcare solutions, including animal health products such as ointments, medicine, and feed additives for dogs and cats.

What does Aratana Therapeutics focus on?

Aratana Therapeutics is a pharmaceuticals company that focuses on the licensing, development, and distribution of drugs and other pharmaceutical products for cats and dogs, including treatments for cancer, viral diseases, and allergies.

What factors should investors consider before investing in pet care stocks?

Before investing in pet care stocks, investors should carefully evaluate factors such as competition, financials, brand value, market share, innovation, and the supply chain and distribution of companies in the industry.

What is the growth rate of the pet care industry?

The pet care industry is experiencing rapid growth globally, with the U.S. pet industry estimated to reach $86 billion by the end of 2018.

Related Posts

Leave a Reply

Your email address will not be published. Required fields are marked *